Japan's Topix index reached a record high on Friday. This happened despite pharmaceutical shares facing pressure. The Nikkei index, however...

Aurobindo Pharma will manufacture and supply long-acting injectable HIV treatment, cabotegravir, across 133 countries through a voluntary l...

Nikkei witnessed a slight dip, ending a seven-session winning streak. Pharma stocks fell after Donald Trump's tariff announcement. Automake...

Orchid Pharma, backed by Dhanuka Group, focuses on cephalosporin antibiotics. Expansion plans include a new facility, Enmetazobactam launch...

“Three years back, when we started, we had a significant debt. But, today we are a debt-free company and we also have significant investmen...

Investors globally are on edge as surging borrowing costs stoke fears of widespread recession, with most of the world's major central banks...

"The Japanese market fell too much in the previous sessions because of concerns about the impact of the Omicron variant, which is affecting...

Takeda, one of the world's biggest pharmaceutical companies, is not developing its own vaccine but has contracts with several firms to dist...

Sun’s products are part of the long-listed and established prescription brands and includes Parlodel, Lamsil, Nitroderm and Lopressor.

They are scouting for niche manufacturing sites, promising experimental drugs, specialty firms in emerging markets and opportunities in the...

The acquisition will result in a wider offering for Lupin in Japanese market where its sales last fiscal stood at Rs 1,364 crore.

The US court, however, denied the motion of Shionogi for recall of Lupin's already distributed generic Fortamet during the two weeks of at-...

Drug maker Ranbaxy Laboratories today said it has received approval from the US drug regulator for manufacturing and marketing the generic ...

The deal in which Ranbaxy Laboratories Ltd India's largest pharmaceutical company was sold off to a Japanese-based Daiichi Sankyo Co has be...